Heather Rowe Armstrong

Vice President, Investor Relations and Corporate Communications

Ms. Armstrong has served as Vice President, Investor Relations and Corporate Communications since March 2020. Previously, Ms. Armstrong was Vice President of Investor Relations and Corporate Communications at Dynavax Technologies Corporation. Before that she was Senior Director of Investor Relations and Corporate Communications at Five Prime Therapeutics. Prior to that, she was Director of Investor Relations at KYTHERA Biopharmaceuticals (acquired by Allergan). She previously held various investor relations and communications roles with increasing responsibility at AeroVironment, Allos Therapeutics (acquired by Spectrum Pharmaceuticals), Janus Capital Group and Myogen (acquired by Gilead Sciences). Ms. Armstrong holds an M.A. in Mass Communications/Public Relations from Texas Tech University and a B.A. in Communication Studies, with minors in Marketing and Journalism from New Mexico State University. She is an active member of the National Investor Relations Institute (NIRI) and has served on the board of directors of the NIRI Rocky Mountain Chapter and the NIRI Los Angeles Chapter.